Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$191.17 - $325.63 $46.3 Million - $78.8 Million
241,946 Added 93.67%
500,230 $163 Million
Q4 2023

Feb 12, 2024

SELL
$160.99 - $215.69 $72.2 Million - $96.7 Million
-448,537 Reduced 63.46%
258,284 $49.2 Million
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $13 Million - $19 Million
-66,955 Reduced 8.65%
706,821 $141 Million
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $6.67 Million - $9.05 Million
29,897 Added 4.02%
773,776 $221 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $6.85 Million - $8.51 Million
39,043 Added 5.54%
743,879 $161 Million
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $13 Million - $18.9 Million
63,525 Added 9.91%
704,836 $145 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $24.8 Million - $39.5 Million
127,283 Added 24.76%
641,311 $178 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $102 Million - $190 Million
-884,183 Reduced 63.24%
514,028 $98.3 Million
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $24.6 Million - $39.9 Million
192,525 Added 15.97%
1,398,211 $290 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $17.4 Million - $25.5 Million
-105,263 Reduced 8.03%
1,205,686 $215 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $116 Million - $166 Million
704,446 Added 116.15%
1,310,949 $270 Million
Q2 2021

Aug 17, 2021

BUY
$131.45 - $201.49 $76.6 Million - $117 Million
582,611 Added 2438.52%
606,503 $115 Million
Q1 2021

May 17, 2021

SELL
$92.73 - $142.05 $5.55 Million - $8.5 Million
-59,865 Reduced 71.47%
23,892 $3.11 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $4.68 Million - $7.2 Million
69,430 Added 484.61%
83,757 $8.69 Million
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $613,052 - $1.09 Million
14,327 New
14,327 $1.09 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.